Wow, ATEC threw down on the cervical spine competition this morning, dang. This is not good news for them and great news for ATEC shareholders. Now watch ATEC incorporate their new technology imaging toys into the cervical surgery operating room. The pace of innovation at this company is astounding and its going to drive growth for years to come.
r
Once again the analysts were surprised by management comments regarding the Q. They are in stark contrast to what they heard from other CEO's in the spine business. ATEC did see a the soft end to the Q because of Covid but they still managed to have a great Q. We'll continue to see rapid adoption of ATEC technology in 2021 and beyond.
BTW, the earnings transcript is a must read.
ATEC is disrupting the spine market and they are gaining market share.
r
Fairly significant growth in our institutional ownership in the 4th Q, we had a net increase of around 16.7 million shares. The company pre-announced so guidance will be especially important.
A
When are earnings out?
D
how did insiders buy on march 1st at 11.11$, ? the price was 16$
A
Like this as a small pure play.. profitable growing essential surgery service.. not really sure where it could go long-term.. $20 July calls seemed like pretty good value, scooped some up this morning..
J
Very nice earnings report. ATEC will be on the move north tomorrow, Friday and beyond. Hold long & strong!
Bullish
A
For such good price movement over the past few weeks this board sure is quiet.
r
Nuvasive delivered another horrible Q earnings report last night, revenues decreased 6% for the Q, 10% decrease for year. Management reported a slowdown in spinal surgeries in the US in the 4th Q because of COVID. Funny that ATEC management sighted no such issue in their pre-earnings announcement. Maybe Nuvasive should have told shareholders that they were getting their #$%$ kicked by the company whose CEO was pushed out by their BOD.
r
NuVasive releases earnings tomorrow after the close, it will interesting to hear there comments regarding the spinal business and the COVID affect. Not sure what to expect from them, growth has been very hard to come by. That company has huge institutional ownership and they might be getting a little impatient.
Earnings release, on a Friday, after the close, I'd be worried if I was a shareholder.
B
feel like this company is the best kept secret. kind of like it that way, filters out the noise. nice report
Bullish
j
Pat and Jeff really made me feel good today. I truly hope it crashes tomorrow so I can double my position.
s
$ATEC Reiterated by Piper Sandler Overweight USD 17 » USD 19 Target Raised by HC Wainwright Buy USD 16 » USD 19
M
Yyoo buy it the compnay just bought an huge amount
Bullish
C
ATEC may sell its common shares from time to time, for up to $50 million, separately or together, in aggregate sales proceeds in “at-the-market” transactions.
P
Why I doubled down, one of the strongest statements from a CEO I've ever read either Pat is FOS or this stock is going to be a real revelation. I'm betting on the latter, we are seeing growth while procedures are down when activity gets back to normal I think this will be a winner. "We are just getting started. We expect to see continued strong interest and enthusiasm for the 8 to 10 new solutions we will deliver in the second half of 2020. We could not be more viscerally and personally engaged in our mission and our ability to continue to drive industry-leading growth. We know our best is yet to come." Pat Miles CEO
r
In the 3rd Q, ATEC saw an almost 12 million share increase in our institutional ownership. There were big buyers and many new names on the list. I fully expect that # to increase again this Q. It certainly explains the nice rally we saw and after this consolation phase we should begin the next leg up.
Very much looking forward to the Safe OP launch update. By the time management has the 4th Q conference call they should have a good deal of feedback from the initial and followup sales calls and presentations.
r
Check out the chart for ATEC and then look at Nuvasive. It appears to me we are seeing a rotation of money out of Nuvasive and into ATEC. Those presentations ATEC just did seems to have created some demand for our shares amongst institutional investors. I fully expect an excellent 3rd Q earnings report as the push to get all those spinal surgeries performed that were put off for months.
r
Vicki, this is not shady, this is a result of hard working folks pushing innovation in spinal surgery. This is the result of more and more surgeons adopting ATEC solutions, having successful outcomes for their patients and driving more and more business to ATEC's product line. The pace of innovation at this company is insane and our growth story will continue well into the future.
Short term, the stock will likely see profit taking and selling pressure, we may have gotten ahead of ourselves yesterday (that was big fun). Long term this company is a rock solid investment.
2021 and beyond.
BTW, the earnings transcript is a must read.
ATEC is disrupting the spine market and they are gaining market share.
the spinal business and the COVID affect. Not sure what to expect from them, growth has been very hard
to come by. That company has huge institutional ownership and they might be getting a little impatient.
Earnings release, on a Friday, after the close, I'd be worried if I was a shareholder.
Reiterated by Piper Sandler Overweight USD 17 » USD 19
Target Raised by HC Wainwright Buy USD 16 » USD 19
"We are just getting started. We expect to see continued strong interest and enthusiasm for the 8 to 10 new solutions we will deliver in the second half of 2020. We could not be more viscerally and personally engaged in our mission and our ability to continue to drive industry-leading growth. We know our best is yet to come." Pat Miles CEO
new names on the list. I fully expect that # to increase again this Q. It certainly explains the nice rally we saw and after this
consolation phase we should begin the next leg up.
Very much looking forward to the Safe OP launch update. By the time management has the 4th Q conference call they should
have a good deal of feedback from the initial and followup sales calls and presentations.
out of Nuvasive and into ATEC. Those presentations ATEC just did seems to have created some demand for our shares amongst institutional investors. I fully expect an excellent 3rd Q earnings report as the push to
get all those spinal surgeries performed that were put off for months.
our growth story will continue well into the future.
Short term, the stock will likely see profit taking and selling pressure, we may have gotten ahead of ourselves yesterday (that was big fun). Long term this company is a rock solid investment.